Poliovirus cell entry: Common structural themes in viral cell entry pathways

Annual Review of Microbiology

Volumn 56, Issue , 2002, Pages 677-702

  Hogle, James M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Conformational changes; Spring loaded trap; Virus structure; Virus membrane interactions; Virus receptor interactions

Indexed keywords

CAPSID PROTEIN; VIRUS RNA;

CLINICAL PATHWAY; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; EXPERIMENTAL MODEL; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVIEW; VIRUS ADSORPTION; VIRUS CAPSID; VIRUS CELL TRANSFORMATION; VIRUS ENVELOPE; VIRUS GENE; VIRUS MORPHOLOGY;

CAPSID; HUMANS; MEMBRANE PROTEINS; MODELS, GENETIC; MODELS, MOLECULAR; POLIOVIRUS; RECEPTORS, VIRUS; VIRION; VIRUS INTEGRATION;

HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; POLIOVIRUS; RNA VIRUSES;

EID: 0036403802     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.56.012302.160757     Document Type: Review

References (123)

1. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337:709-16
2. Aoki J, Koike S, Ise I, Sato-Yoshida Y, Nomoto A. 1994. Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J. Biol. Chem. 269:8431-38
3. Arita M, Koike S, Aoki J, Horie H, Nomoto A. 1998. Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J. Virol. 72:3578-86
4. Arnold E, Luo M, Vriend G, Rossmann MG, Palmenberg AC, et al. 1987. Implications of the picomavirus capsid structure for polyprotein processing. Proc. Natl. Acad. Sci. USA 84:21-25
5. Baker KA, Dutch RE, Lamb RA, Jardetzky TS. 1999. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell 3:309-19
6. Basavappa R, Gomez-Yafal A, Hogle JM. 1998. The poliovirus empty capsid specifically recognizes the poliovirus receptor and undergoes some, but not all, of the transitions associated with cell entry. J. Virol. 72:7551-56
7. Basavappa R, Syed R, Flore O, Icenogle JP, Filman DJ, Hogle JM. 1994. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: Structure of the empty capsid assembly intermediate at 2.9 Å resolution. Protein Sci. 3:1651-69
8. Bayer N, Prchla E, Schwab M, Blaas D, Fuchs R. 1999. Human rhinovirus HRV14 uncoats from early endosomes in the presence of bafilomycin. FEBS Lett. 463:175-78
9. Belnap DM, Filman DJ, Trus BL, Cheng N, Booy FP, et al. 2000. Molecular tectonic model of virus structural transitions: The putative cell entry states of poliovirus. J. Virol. 74:1342-54
10. Belnap DM, McDermott BM Jr, Filman DJ, Cheng N, Trus BL, et al. 2000. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc. Natl. Acad. Sci. USA 97:73-78
11. Bergelson JM, Chan M, Solomon KR, St. John NF, Lin H, Finberg RW. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA 91:6245-48
12. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, et al. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-23
13. Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, et al. 1998. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J. Virol. 72:415-19
14. Bergelson JM, Shepley MP, Chan BMC, Hemler ME, Finberg RW. 1995. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:1718-20
15. Bernhardt G, Harber J, Zibert A, DeCrombrugghe M, Wimmer E. 1994. The poliovirus receptor: Identification of domains and amino acid residues critical for virus binding. Virology 203:344-56
16. Bothner B, Dong XF, Bibbs L, Johnson JE, Siuzdak G. 1998. Evidence of viral capsid dynamics using limited proteolysis and mass spectrometry. J. Biol. Chem. 273:673-76
17. Bouchard MJ, Dong Y, McDermott BM Jr, Lam DH, Brown KR, et al. 2000. Defects in nuclear and cytoskeletal morphology and mitochondrial localization in spermatozoa of mice lacking nectin-2, a component of cell-cell adherens junctions. Mol. Cell Biol. 20:2865-73
18. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43
19. Casasnovas JM, Springer TA. 1995. Kinetics and thermodynamics of virus binding to receptor. Studies with rhinovirus, intercellular adhesion molecule-1 (ICAM-1), and surface plasmon resonance. J. Biol. Chem. 270:13216-24
20. Chan DC, Fass D, Berger JM, Kim PS. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-73
21. Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. 1998. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409-17
22. Chow M, Newman JFE, Filman D, Hogle JM, Rowlands DJ, Brown F. 1987. Myristylation of picomavirus capsid protein VP4 and its structural significance. Nature 327:482-86
23. Colston E, Racaniello VR. 1994. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J. 13:5855-62
24. Colston EM, Racaniello VR. 1995. Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J. Virol. 69:4823-29
25. Couderc T, Guédo N, Calvez V, Pelletier I, Hogle J, et al. 1994. Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice. J. Virol. 68:8386-91
26. Couderc T, Hogle J, Le Blay H, Horaud F, Blondel B. 1993. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: Involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell. J. Virol. 67:3808-17
27. Curry S, Chow M, Hogle JM. 1996. The poliovirus 135S particle is infectious. J. Virol. 70:7125-31
28. Damke H, Baba T, Warnock DE, Schmid SL. 1994. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell Biol. 127:915-34
29. De Sena J, Mandel B. 1977. Studies on the in vitro uncoating of poliovirus. II. Characteristics of the membrane-modified particle. Virology 78:554-66
30. DeTulleo L, Kirchhausen T. 1998. The clathrin endocytic pathway in viral infection. EMBO J. 17:4585-93
31. Dove AW, Racaniello VR. 1997. Cold-adapted poliovirus mutants bypass a post-entry replication block. J. Virol. 71:4728-35
32. Fass D, Harrison SC, Kim PS. 1996. Retrovirus envelope domain at 1.7 angstrom resolution. Nat. Struct. Biol. 3:465-69
33. Fenwick ML, Cooper PD. 1962. Early interactions between poliovirus and ERK cells. Some observations on the nature and significance of the rejected particles. Virology 18:212-23
34. Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle JM. 1989. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:1567-79
35. Filman DJ, Wien MW, Cunningham JA, Bergelson JM, Hogle JM. 1998. Structure determination of echovirus 1. Acta Crystallogr. D 54:1261-72
36. Fricks CE, Hogle JM. 1990. Cell-induced conformational change of poliovirus: Externalization of the amino terminus of VP1 is responsible for liposome binding. J. Virol. 64:1934-45
37. Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, et al. 1999. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J. 18:543-54
38. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280:1618-20
39. Golden J, Harrison SC. 1982. Proteolytic dissection of turnip crinkle virus subunit in solution. Biochemistry 21:3862-66
40. Gomez Yafal A, Kaplan G, Racaniello VR, Hogle JM. 1993. Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology 197:501-5
41. Grant RA, Filman DJ, Fujinami RS, Icenogle JP, Hogle JM. 1992. Three-dimensional structure of Theiler virus. Proc. Natl. Acad. Sci. USA 89:2061-65
42. Grant RA, Hiremath C, Filman DJ, Syed R, Andries K, Hogle JM. 1994. Structures of poliovirus complexes with antiviral drugs: Implications for viral stability and drug design. Curr. Biol. 4:784-97
43. Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, et al. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839-47
44. Hadfield AT, Lee W-M, Zhao R, Oliveira MA, Minor I, et al. 1997. The refined structure of human rhinovirus 16 at 2.15 Å resolution: Implications for the viral life cycle. Structure 5:427-41
45. Harber JJ, Bradley J, Anderson CW, Wimmer E. 1991. Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2. J. Virol. 65:326-34
46. He Y, Bowman VD, Mueller S, Bator CM, Bella J, et al. 2000. Interaction of the poliovirus receptor with poliovirus. Proc. Natl. Acad. Sci. USA 97:79-84
47. He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, et al. 2001. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat. Struct. Biol. 8:874-78
48. Hendry E, Hatanaka H, Fry E, Smyth M, Tate J, et al. 1999. The crystal structure of coxsackievirus A9: New insights into the uncoating mechanisms of enteroviruses. Struct. Fold Des. 7:1527-38
49. Hewat EA, Neumann E, Conway JF, Moser R, Ronacher B, et al. 2000. The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: A structural view. EMBO J. 19:6317-25
50. Hindiyeh M, Li QH, Basavappa R, Hogle JM, Chow M. 1999. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. J. Virol. 73:9072-79
51. Hofer F, Gruenberger M, Kowalski H, Machat H, Huettinger M, et al. 1994. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci. USA 91:1839-42
52. Hogle JM, Chow M, Filman DJ. 1985. Three-dimensional structure of poliovirus at 2.9. Å resolution. Science 229:1358-65
53. Huang Y, Hogle JM, Chow M. 2000. Is the 135S poliovirus particle an intermediate during cell entry? J. Virol. 74:8757-61
54. Incardona NL, Kaesberg P. 1964. A pH-induced structural change in bromegrass mosaic virus. Biophys. J. 4:11-21
55. Kaplan G, Freistadt MS, Racaniello VR. 1990. Neutralization of poliovirus by cell receptors expressed in insect cells. J. Virol. 64:4697-702
56. Kim S, Smith TJ, Chapman MS, Rossmann MG, Pevear DC, et al. 1989. Crystal structure of human rhinovirus serotype 1A (HRV1A). J. Mol. Biol. 210:91-111
57. Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, et al. 1981. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 291:547-53
58. Koike S, Ise I, Nomoto A. 1991. Functional domains of the poliovirus receptor. Proc. Natl. Acad. Sci. USA 88:4104-8
59. Kolatkar PR, Bella J, Olson NH, Bator CM, Baker TS, Rossmann MG. 1999. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO J. 18:6249-59
60. Deleted in proof
61. Lamb RA, Joshi SB, Dutch RE. 1999. The paramyxovirus fusion protein forms an extremely stable core trimer: structural parallels to influenza virus haemagglutinin and HIV-1 gp41. Mol. Membr. Biol. 16:11-19
62. Lentz KN, Smith AD, Geisler SC, Cox S, Buontempo P, et al. 1997. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: Comparison of the structural and biological properties of three poliovirus serotypes. Structure 5:961-78
63. Lewis JK, Bothner B, Smith TJ, Siuzdak G. 1998. Antiviral agent blocks breathing of the common cold virus. Proc. Natl. Acad. Sci. USA 95:6774-78
64. Li Q, Yafal AG, Lee YM-H, Hogle J, Chow M. 1994. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J. Virol. 68:3965-70
65. Luo M, He C, Toth KS, Zhang CX, Lipton HL. 1992. Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc. Natl. Acad. Sci. USA 89:2409-13
66. Luo M, Toth KS, Zhou L, Pritchard A, Lipton HL. 1996. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology 220:246-50
67. Luo M, Vriend G, Kamer G, Minor I, Arnold E, et al. 1987. The atomic structure of Mengo virus at 3.0 Å resolution. Science 235:182-91
68. Macadam AJ, Arnold C, Howlett J, John A, Marsden S, et al. 1989. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 172:408-14
69. Macadam AJ, Ferguson M, Arnold C, Minor PD. 1991. An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J. Virol. 65:5225-31
70. Madshus IH, Olsnes S, Sandvig K. 1984. Requirements for entry of poliovirus into cells at low pH. EMBO J. 3:1945-50
71. Malashkevich VN, Chan DC, Chutkowski CT, Kim PS. 1998. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc. Natl. Acad. Sci. USA 95:9134-39
72. Malashkevich VN, Schneider BJ, McNally ML, Milhollen MA, Pang JX, Kim PS. 1999. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9 Å resolution. Proc. Natl. Acad. Sci. USA 96:2662-67
73. Martin A, Benichou D, Couderc T, Hogle JM, Wychowski C, et al. 1991. Use of type 1/type 2 chimaeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model. Virology 180:648-58
74. Martin A, Wychowski C, Couderc T, Crainic R, Hogle J, Girard M. 1988. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J. 7:2839-47
75. McDermott BM, Rux AH, Eisenberg RJ, Cohen GH, Racaniello VR. 2000. Two distinct binding affinities of poliovirus for its cellular receptor. J. Biol. Chem. 275:23089-96
76. Mendelsohn CL, Wimmer E, Racaniello VR. 1989. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56:855-65
77. Molla A, Paul AV, Wimmer E. 1991. Cell-free, de novo synthesis of poliovirus. Science 254:1647-51
78. Molla A, Paul AV, Wimmer E. 1993. In vitro synthesis of poliovirus. Dev. Biol. Stand. 78:39-53
79. Morrison ME, He YJ, Wien MW, Hogle JM, Racaniello VR. 1994. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 68:2578-88
80. Morrison ME, Racaniello VR. 1992. Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J. Virol. 66:2807-13
81. Moss EG, Racaniello VR. 1991. Host range determinants located on the interior of the poliovirus capsid. EMBO J. 10:1067-74
82. Mosser AG, Rueckert RR. 1993. WIN 51711-dependent mutants of poliovirus type 3: Evidence that virions decay after release from cells unless drug is present. J. Virol. 67:1246-54
83. Mosser AG, Sgro JY, Rueckert RR. 1994. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions. J. Virol. 68:8193-201
84. Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, et al. 1995. The structure of coxsackievirus B3 at 3.5 Å resolution. Structure 3:653-67
85. Oliveira MA, Zhao R, Lee WM, Kremer MJ, Minor I, et al. 1993. The structure of human rhinovirus 16. Structure 1:51-68
86. Olson NH, Kolatkar PR, Oliveira MA, Cheng RH, Greve JM, et al. 1993. Structure of a human rhinovirus complexed with its receptor molecule. Proc. Natl. Acad. Sci. USA 90:507-11
87. Pallansch MA, Kew O, Semler BL, Omilianowski DR, Anderson CW, et al. 1984. Protein processing map of poliovirus. J. Virol. 49:873-80
88. Perez L, Carrasco L. 1993. Entry of poliovirus into cells does not require a lowpH step. J. Virol. 67:4543-48
89. Phelps D, Post C. 1999. Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus. Protein Sci. 8:2281-89
90. Phelps DK, Speelman B, Post CB. 2000. Theoretical studies of viral capsid proteins. Curr. Opin. Struct. Biol. 10:170-73
91. Prchla E, Kuechler E, Blaas D, Fuchs R. 1994. Uncoating of human rhinovirus serotype 2 from late endosomes. J. Virol. 68:3713-23
92. Racaniello VR. 2001. Picornaviridae: The viruses and their replication. In Fields Virology, ed. D. Knipe, P. Howley, pp. 685722. New York: Lippincott Williams & Wilkens
93. Robinson IK, Harrison SC. 1982. Structure of the expanded state of tomato bushy stunt virus. Nature 297:563-68
94. Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, et al. 1985. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317:145-53
95. Rossmann MG, Bella J, Kolatkar PR, He Y, Wimmer E, et al. 2000. Cell recognition and entry by rhino- and enteroviruses. Virology 269:239-47
96. Selinka H-C, Zibert A, Wimmer E. 1991. Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway. Proc. Natl. Acad. Sci. USA 88:3598-602
97. Selinka H-C, Zibert A, Wimmer E. 1992. A chimeric poliovirus/CD4 receptor confers susceptibility to poliovirus on mouse cells. J. Virol. 66:2523-26
98. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD. 1995. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 69:3873-77
99. Shukla D, Rowe CL, Dong Y, Racaniello VR, Spear PG. 1999. The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J. Virol. 73:4493-97
100. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 69:531-69
101. Smith TJ, Chase ES, Schmidt TJ, Olson NH, Baker TS. 1996. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. Nature 383:350-54
102. Smith TJ, Kremer MJ, Luo M, Vriend G, Arnold E, et al. 1986. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286-93
103. Smith TJ, Olson NH, Cheng RH, Liu H, Chase ES, et al. 1993. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. J. Virol. 67:1148-58
104. Smyth M, Tate J, Hoey E, Lyons C, Martin S, Stuart D. 1995. Implications for viral uncoating from the structure of bovine enterovirus. Struct. Biol. 2:224-31
105. Speelman B, Brooks BR, Post CB. 2001. Molecular dynamics simulations of human rhinovirus and an antiviral compound. Biophys. J. 80:121-29
106. Speir JA, Munshi S, Wang G, Baker TS, Johnson JE. 1995. Structures of the native and swollen forms of cowpea chlorotic mottle virus determined by X-ray crystallography and cryo-electron microscopy. Structure 3:63-78
107. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA. 1989. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56:849-53
108. Takahashi K, Nakanishi H, Miyahara M, Mandai K, Satoh K, et al. 1999. Nectin/PRR: An immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. J. Cell Biol. 145:539-49
109. Tosteson MT, Chow M. 1997. Characterization of the ion channels formed by poliovirus in planar lipid membranes. J. Virol. 71:507-11
110. Tsang SK, Danthi P, Chow M, Hogle JM. 2000. Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects. J. Mol. Biol. 296:335-40
111. Tsang SK, McDermott BM, Racaniello VR, Hogle JM. 2001. A kinetic analysis of the effect of poliovirus receptor on viral uncoating: The receptor as a catalyst. J. Virol. 75:4984-89
112. Verdaguer N, Blaas D, Fita I. 2000. Structure of human rhinovirus serotype 2 (HRV2). J. Mol. Biol. 300:1179-94
113. Weissenhorn W, Calder LJ, Wharton SA, Skehel JJ, Wiley DC. 1998. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc. Natl. Acad. Sci. USA 95:6032-36
114. Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387:426-30
115. Wetz K, Kucinski T. 1991. Influence of different ionic and pH environments on structural alterations of poliovirus and their possible relation to virus uncoating. J. Gen. Virol. 72:2541-44
116. Wien MW, Curry S, Filman DJ, Hogle JM. 1997. Structural studies of poliovirus mutants that overcome receptor defects. Nat. Struct. Biol. 4:666-74
117. Wiley DC, Skehel JJ. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:365-94
118. Wilson IA, Skehel JJ, Wiley DC. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366-73
119. Xiao C, Bator CM, Bowman VD, Rieder E, He Y, et al. 2001. Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1. J. Virol. 75:2444-51
120. Xing L, Tjarnlund K, Lindqvist B, Kaplan GG, Feigelstock D, et al. 2000. Distinct cellular receptor interactions in poliovirus and rhinoviruses. EMBO J. 19:1207-16
121. Yeates TO, Jacobson DH, Martin A, Wychowski C, Girard M, et al. 1991. Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera. EMBO J. 10:2331-41
122. Zhao R, Pevear DC, Kremer MJ, Giranda VL, Kofron JA, et al. 1996. Human rhinovirus 3 at 3.0 Å resolution. Structure 4:1205-20
123. Zhao X, Singh M, Malashkevich VN, Kim PS. 2000. Structural characterization of the human respiratory syncytial virus fusion protein core. Proc. Natl. Acad. Sci. USA 97:14172-77